Product Information
ESCITALOPRAM 5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0455 per EA under NDC 33342003611. Its NADAC has been published 575 times since May 14, 2014.
FDA first approved this application on Sep 11, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342003611
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA202210FDA Approved
9/11/2012
TE Code
AB
On Market Since
9/11/2012
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 5 MG TABLET has been published 575 times since May 14, 2014, and over the history we have for it it has declined 71.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0455 per EA |
|---|---|
| All-time high | $0.1852 (Mar 11, 2015) |
| All-time low | $0.0328 (Nov 20, 2024) |
| Median price | $0.0643 |
| Average price | $0.0798 |
| Largest weekly change | +44.7% (Jun 22, 2016) |
| Weeks tracked | 575 |
| Tracking since | May 14, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-5.5%
5Y
-22.9%
All
-71.4%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0455 per EA (NDC 33342003611), effective May 14, 2025.
How has the price of ESCITALOPRAM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has declined 71.4%. It has been tracked across 575 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?
Since May 14, 2014, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Nov 20, 2024) to a high of $0.1852 (Mar 11, 2015), with a median of $0.0643 per EA.
Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESCITALOPRAM 5 MG TABLET, is $0.0412 per EA — about 9% below ESCITALOPRAM 5 MG TABLET.
Who manufactures ESCITALOPRAM 5 MG TABLET?
ESCITALOPRAM 5 MG TABLET (NDC 33342003611) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.